These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29789176)

  • 1. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives.
    de Geus E; Eijzenga W; Menko FH; Sijmons RH; de Haes HC; Aalfs CM; Smets EM
    J Genet Couns; 2016 Dec; 25(6):1179-1187. PubMed ID: 27103421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.
    Hayat Roshanai A; Lampic C; Rosenquist R; Nordin K
    Fam Cancer; 2010 Dec; 9(4):669-79. PubMed ID: 20577820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives.
    de Geus E; Aalfs CM; Menko FH; Sijmons RH; Verdam MG; de Haes HC; Smets EM
    Int J Behav Med; 2015 Aug; 22(4):551-60. PubMed ID: 25515913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of dispositional optimism on post-visit anxiety and risk perception accuracy among breast cancer genetic counselees.
    Wiering BM; Albada A; Bensing JM; Ausems MG; van Dulmen AM
    Psychooncology; 2013 Nov; 22(11):2419-27. PubMed ID: 23630180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences.
    Pieterse AH; Ausems MG; Van Dulmen AM; Beemer FA; Bensing JM
    Am J Med Genet A; 2005 Aug; 137(1):27-35. PubMed ID: 16007615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
    Albada A; van Dulmen S; Bensing JM; Ausems MG
    Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.
    Albada A; van Dulmen S; Lindhout D; Bensing JM; Ausems MG
    Fam Cancer; 2012 Mar; 11(1):85-95. PubMed ID: 21901499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
    Hawranek C; Rosén A; Hajdarevic S
    Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling.
    Albada A; van Dulmen S; Spreeuwenberg P; Ausems MG
    Patient Educ Couns; 2015 Jan; 98(1):69-76. PubMed ID: 25455796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes?
    Medendorp NM; Hillen MA; Visser LNC; Aalfs CM; Duijkers FAM; van Engelen K; Ausems MGEM; Verhoef S; Stiggelbout AM; Smets EMA
    Eur J Hum Genet; 2021 May; 29(5):789-799. PubMed ID: 33437034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
    Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial.
    Eijzenga W; Bleiker EM; Ausems MG; Sidharta GN; Van der Kolk LE; Velthuizen ME; Hahn DE; Aaronson NK
    Clin Genet; 2015 May; 87(5):419-27. PubMed ID: 25130962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial.
    Eijzenga W; Aaronson NK; Hahn DE; Sidharta GN; van der Kolk LE; Velthuizen ME; Ausems MG; Bleiker EM
    J Clin Oncol; 2014 Sep; 32(27):2998-3004. PubMed ID: 25049325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.